Results 81 to 90 of about 19,471 (205)
Clinical and Translational Science, Volume 19, Issue 9, September 2026.ABSTRACT Pairwise drug–drug interaction databases flag co‐prescribed pairs, but they under‐weight multi‐drug combinations that drive adverse drug events in older adults. We studied that gap in Virginia All‐Payer Claims Database records (2016–2019) for adults aged 65–114 years with non‐opioid emergency department visits (n = 1182 cases; 16,105 matched ...
R. Jerome Dixon, Elvin T. Price
wiley +1 more source
Carvedilol for prevention of atrial fibrillation after cardiac surgery: a meta-analysis.
PLoS ONE, 2014 BackgroundPostoperative atrial fibrillation (POAF) remains the most common complication after cardiac surgery. Current guidelines recommend β-blockers to prevent POAF. Carvedilol is a non-selective β-adrenergic blocker with anti-inflammatory, antioxidant,
Hui-Shan Wang +2 more
doaj +1 more source
Pathology International, Volume 76, Issue 9, September 2026.Anti‐centromere antibody‐positive primary biliary cholangitis‐spectrum disease may present with portal hypertension disproportionate to liver stiffness. In this series of three patients, portal tract‐based histology showed portal venopathy with porto‐sinusoidal vascular disorder‐spectrum features, supported by venographic, elastographic, and ...
Yuya Ando +6 more
wiley +1 more source
Dose of carvedilol at each follow-up.
, 2018 Among 394 patients in the carvedilol group, 12 patients did not receive the assigned carvedilol treatment; prescription of bisoprolol in 7 patients and no prescription of beta-blocker in 5 patients (protocol violation).
Kazushige Kadota (665891) +26 more
core +1 more source
Carvedilol inhibits the mitochondrial permeability transition by an antioxidant mechanism [PDF]
, 2004 It was previously shown that carvedilol, a ß-adrenergic receptor antagonist with antioxidant properties, was able to inhibit the mitochondrial permeability transition (MPT).
Palmeira, Carlos +4 more
core +1 more source
Post-carvedilol myocardial function in cats with obstructive hypertrophic cardiomyopathy
Frontiers in Veterinary ScienceIntroductionHypertrophic cardiomyopathy (HCM) is the most prevalent cardiac disease in cats, and one phenotype includes obstructive HCM with dynamic left ventricular outflow tract obstruction (DLVOTO). Myocardial function has been reported to be lower in
Takahiro Saito +9 more
doaj +1 more source
Annals of Hepatology, 2014 Background. Carvedilol appears to be more effective than propranolol in the treatment of portal hypertension in cirrhotic patients.Aim. To compare the effects of carvedilol vs.
Nancy Aguilar-Olivos +6 more
doaj +1 more source
Comparison of Metoprolol versus Carvedilol After Acute Myocardial Infarction
, 2021 Beta-blockers are typically prescribed following myocardial infarction (MI), but no specific beta-blocker is recommended. Of 7,057 patients enrolled in the OBTAIN multi-center registry of patients with acute MI, 4142 were discharged on metoprolol and ...
Goldberger, Jeffrey J +7 more
core +1 more source
Skin Cancer Prevention by Carvedilol
, 2015 Since approximately 90 percent of diagnosed non-melanoma skin cancers are associated with exposure to ultraviolet (UV) radiation from the sun, the primary form being UVB irradiation, we hypothesized that carvedilol will prevent UVB-induced skin ...
Huang, Kevin M.
core +1 more source
Carvedilol reduces mitochondrial damage induced by hypoxanthine/xanthine oxidase [PDF]
, 2001 The cardioprotective properties of new pharmaceuticals such as carvedilol might be explained by enhanced mitochondrial protection. The aim of this work was to determine the role of carvedilol in the protection of heart mitochondria from oxidative damage ...
Palmeira, Carlos +3 more
core +1 more source